Aug 22, 2022

ADCs Built On Starpharma Delivery Tech To Be Tested By Merck

"As it works to expand its antibody-drug conjugate (ADC) capabilities, Merck has strengthened its links to Starpharma by signing a second partnership that will allow it to assess potential candidates using a dendrimer drug delivery technology", reports World Pharma Today. Read the full article here.

 This contains certain forward-looking statements.